These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19015955)

  • 21. Influence of age and cytochrome P450 2C9 genotype on the steady-state disposition of diclofenac and celecoxib.
    Brenner SS; Herrlinger C; Dilger K; Mürdter TE; Hofmann U; Marx C; Klotz U
    Clin Pharmacokinet; 2003; 42(3):283-92. PubMed ID: 12603175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
    Götz J; Sauter R; Steinijans VW; Jonkman JH
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):168-73. PubMed ID: 8032575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of diazepam from a controlled release capsule in healthy elderly volunteers.
    Wills RJ
    Biopharm Drug Dispos; 1984; 5(3):241-9. PubMed ID: 6487752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic profile of intramuscular fulvestrant in advanced breast cancer.
    Robertson JF; Erikstein B; Osborne KC; Pippen J; Come SE; Parker LM; Gertler S; Harrison MP; Clarke DA
    Clin Pharmacokinet; 2004; 43(8):529-38. PubMed ID: 15170367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibition.
    Cawello W; Boekens H; Waitzinger J; Miller U
    Int J Clin Pharmacol Ther; 2002 Jan; 40(1):9-17. PubMed ID: 11837383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of a once-daily treatment using ciprofloxacin in an extended-release dosage form.
    Schuck EL; Dalhoff A; Stass H; Derendorf H
    Infection; 2005 Dec; 33 Suppl 2():22-8. PubMed ID: 16518708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steady-state bioavailability of two clorazepate dipotassium dosage forms.
    Carrigan PJ; Chao GC; Barker WM; Hoffman DJ; Chun AH
    J Clin Pharmacol; 1977 Jan; 17(1):18-28. PubMed ID: 13089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Criteria to assess in vivo performance of sustained release products: application to diltiazem formulations.
    Bialer M; Sussan S; Abu Salach O; Danenberg HD; Ben-David J; Gibor Y; Laor A
    J Pharm Sci; 1995 Oct; 84(10):1160-3. PubMed ID: 8801328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine.
    Chung M; Reitberg DP; Gaffney M; Singleton W
    Am J Med; 1987 Dec; 83(6B):10-4. PubMed ID: 3503594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamic and pharmacokinetic rationales for the development of an oral controlled-release amoxicillin dosage form.
    Hoffman A; Danenberg HD; Katzhendler I; Shuval R; Gilhar D; Friedman M
    J Control Release; 1998 Jun; 54(1):29-37. PubMed ID: 9741901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
    Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nomogram to predict the best biological half-life values for candidates for oral prolonged-release formulations.
    Zhou M; Notari RE
    J Pharm Sci; 1996 Aug; 85(8):791-5. PubMed ID: 8863265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-in-Class Analgesic.
    Kleideiter E; Piana C; Wang S; Nemeth R; Gautrois M
    Clin Pharmacokinet; 2018 Jan; 57(1):31-50. PubMed ID: 28623508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of enprofylline administered intravenously and as a sustained-release tablet at steady state in children with asthma.
    Watson WT; Simons KJ; Simons FE
    J Pediatr; 1988 Apr; 112(4):658-62. PubMed ID: 3351694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of terbutaline given in slow-release tablets.
    Nyberg L; Kennedy BM
    Eur J Respir Dis Suppl; 1984; 134():119-39. PubMed ID: 6586473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic evaluation of tapentadol extended-release tablets in healthy subjects.
    Zannikos PN; Smit JW; Stahlberg HJ; Wenge B; Hillewaert VM; Etropolski MS
    J Opioid Manag; 2013; 9(4):291-300. PubMed ID: 24353023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of fluconazole in loggerhead sea turtles (Caretta caretta) after single intravenous and subcutaneous injections, and multiple subcutaneous injections.
    Mallo KM; Harms CA; Lewbart GA; Papich MG
    J Zoo Wildl Med; 2002 Mar; 33(1):29-35. PubMed ID: 12216790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs.
    Hughes MA; Glass PS; Jacobs JR
    Anesthesiology; 1992 Mar; 76(3):334-41. PubMed ID: 1539843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety, tolerability, and pharmacokinetics of the selective prostacyclin receptor agonist ralinepag in single and multiple dosing studies of an immediate-release oral formulation in healthy volunteers.
    Grundy JS; King CD; Adams JW; Cabell CH
    Pulm Circ; 2020; 10(2):2045894020922814. PubMed ID: 32489643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic overview of indomethacin and sustained-release indomethacin.
    Yeh KC
    Am J Med; 1985 Oct; 79(4C):3-12. PubMed ID: 3904441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.